Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Proof-of-concept Clinical Trial Evaluating the Safety and Tolerability of Midodrine in Hepatopulmonary Syndrome

NCT03600870 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT03600870
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03600870 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Proof-of-concept Clinical Trial Evaluating the Safety and Tolerability of Midodrine in Hepatopulmonary Syndrome
Lead sponsor
Mayo Clinic
Phase
Phase 1
Overall status
Completed
Start date
August 2, 2018
Completion date
December 1, 2020
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatopulmonary syndrome (hps)